Projected Income Statement: Repligen Corporation

Forecast Balance Sheet: Repligen Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -238 -339 -682 -232 -23.8 -255 -432 -649
Change - -42.44% -101.18% 65.98% 89.74% -971.07% -69.41% -50.23%
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Repligen Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 67.09 84.83 36.22 25.68 23.52 27.81 32.8 37.94
Change - 26.45% -57.3% -29.11% -8.4% 18.24% 17.96% 15.66%
Free Cash Flow (FCF) 1 51.93 87.25 77.7 149.7 93.9 122.9 148.4 197.4
Change - 68.02% -10.95% 92.7% -37.28% 30.89% 20.75% 32.99%
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Repligen Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 34.38% 30.8% 20.03% 18.48% 19.01% 20.45% 21.98% 23.74%
EBIT Margin (%) 32.09% 28.97% 14.76% 12.94% 13.79% 15.54% 17.3% 19.38%
EBT Margin (%) 22.9% 27.34% 10.04% -4.26% 8.45% 8.26% 12.19% 15%
Net margin (%) 19.13% 23.2% 6.51% -4.02% 6.62% 7.43% 10.71% 13.21%
FCF margin (%) 7.74% 10.89% 12.16% 23.6% 12.72% 14.97% 15.72% 18.12%
FCF / Net Income (%) 40.48% 46.92% 186.87% -586.8% 192.04% 201.56% 146.77% 137.23%

Profitability

        
ROA 8.23% 7.72% 3.68% 3.14% 3.35% 2.57% 5.67% 4.69%
ROE 10.69% 10.3% 5.07% 4.51% 4.75% 4.56% 8.05% 7.51%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 10.01% 10.58% 5.67% 4.05% 3.19% 3.39% 3.47% 3.48%
CAPEX / EBITDA (%) 29.1% 34.36% 28.31% 21.9% 16.76% 16.56% 15.81% 14.67%
CAPEX / FCF (%) 129.2% 97.23% 46.62% 17.15% 25.05% 22.63% 22.1% 19.22%

Items per share

        
Cash flow per share 1 3.862 4.096 2.174 2.046 2.076 2.541 3.276 4.107
Change - 6.05% -46.92% -5.86% 1.44% 22.39% 28.96% 25.35%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 30.56 34.39 35.35 35.17 37.39 38.94 41.7 46.07
Change - 12.53% 2.78% -0.5% 6.32% 4.15% 7.07% 10.48%
EPS 1 2.24 3.24 0.74 -0.46 0.86 1.088 1.802 2.551
Change - 44.64% -77.16% -162.16% 286.96% 26.48% 65.68% 41.53%
Nbr of stocks (in thousands) 55,289 55,524 55,832 56,027 56,291 56,408 56,408 56,408
Announcement Date 2/17/22 2/22/23 2/21/24 2/20/25 2/24/26 - - -
1USD
Estimates
2026 *2027 *
P/E 129x 77.7x
PBR 3.6x 3.36x
EV / Sales 9.32x 7.91x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
140.09USD
Average target price
178.05USD
Spread / Average Target
+27.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
  4. Financials Repligen Corporation